STRS Ohio’s Alder Biopharmaceuticals ALDR Stock Holding History

STRS Ohio’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-21,600	Closed	-$500K	–	1953
2015 Q4	$713K	Sell	21,600 -2,100	-9%	-$71K	﹤0.01%	1024
2015 Q3	$776K	Buy	23,700 +3,300	+16%	+$140K	﹤0.01%	968
2015 Q2	$1.08M	Sell	20,400 -4,400	-18%	-$160K	﹤0.01%	813
2015 Q1	$715K	Sell	24,800 -1,300	-5%	-$35.7K	﹤0.01%	1018
2014 Q4	$759K	Buy	26,100 +10,400	+66%	+$187K	﹤0.01%	972
2014 Q3	$199K	Buy	+15,700	New	+$237K	﹤0.01%	1463

Other funds holding ALDR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

STRS Ohio's ALDR Position: Q1 2016 in Review

STRS Ohio sold out of Alder Biopharmaceuticals (ALDR) in Q1 2016, closing a stake of 21,600 shares — an estimated $500K sold.

STRS Ohio first reported a position in ALDR in Q3 2014 and held it in 6 quarters. The position peaked at $1.08M in Q2 2015. 117 funds tracked by Wall St. Rank hold ALDR as of Q1 2016.

STRS Ohio reported no remaining Alder Biopharmaceuticals position as of Q1 2016 after selling out during the quarter.
STRS Ohio sold 21,600 Alder Biopharmaceuticals shares in Q1 2016, an estimated $500K.
STRS Ohio first reported a position in Alder Biopharmaceuticals in Q3 2014 and held it in 6 quarters.
STRS Ohio's Alder Biopharmaceuticals position peaked at $1.08M in Q2 2015.
117 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q1 2016.

Based on STRS Ohio's 13F filing for Q1 2016, filed 21 Apr 2016.